Having knowledge about your own health conditions or your risk of developing different conditions can help you take steps to maintain or improve your health. Although previous studies have examined general cancer knowledge, no prior study has examined whether women actually know and understand the details about their own cancers. Rachel Freedman, MD, MPH, of the Dana-Farber Cancer Institute in Boston, and her colleagues surveyed 500 women with breast cancer to see how knowledgeable they were about their own cancers, including the tumor stage, grade, and receptor status (also known as breast cancer subtype). Overall, 32 percent to 82 percent reported that they knew each of the tumor characteristics that they were asked about, while only 20 percent to 58 percent actually reported these characteristics correctly. Black and Hispanic women were often less likely than white women to know their cancer characteristics, even after accounting for socioeconomic status and health literacy. After accounting for health literacy and educational attainment in particular, some of the knowledge deficits went away for Hispanic women but health literacy had little impact on the findings for black women.
“Our results illustrate the lack of understanding many patients have about their cancers and have identified a critical need for improved patient education and provider awareness of this issue,” said Dr. Freedman. “Improving patients’ understanding about why a particular treatment is important for her individual situation may lead to more informed decisions and better adherence to treatment.” Dr. Freedman noted that improved understanding of one’s tumor characteristics and the reasons for personalized treatment recommendations could also improve a woman’s trust, confidence, and satisfaction with her cancer treatment providers.
Media wishing to receive a PDF of this article may contact [email protected] (Would you prefer to access this paper instantly? You can register for a login to our Press Room here.)
Article: Racial/ethnic disparities in knowledge about one’s breast cancer characteristics.” Rachel A. Freedman, Elena M. Kouri, Dee W. West, and Nancy L. Keating; Published Online: January 26, 2015 (DOI: 10.1002/cncr.28977).
Author Contact: John Noble of the Dana-Farber Cancer Institute’s Department of Communications at +1 (617) 632-5784 or [email protected]ci.harvard.edu.
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer. CANCER is published by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley’s global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company’s website can be accessed at http://www.wiley.com.
Evelyn Martinez (US) +1 201 748 6358
Tom Griffin (UK) +44 (0) 1865 476213